Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The aim of the present Paris Prospective Study III (PPS3) is (1) to assess the determinants of the regulation of heart rate and blood pressure variations and carotid properties (under different physiologic stimulations) and (2) to evaluate the respective contribution of heart rate, blood pressure variations and carotid properties to cardiovascular morbidity and mortality including sudden death during 10 years at least in healthy considered subjects.
Full description
Overall, 10 157 men and women have been recruited during May 2008 and June 2012 for an extensive clinical examination including a 2h holter electrocardiography (ECG), a carotid doppler echo tracking, a step test, as well as blood and DNA collections. Since then, the cardiovascular morbidity and mortality of the participants is being followed up for 10 years at least and will continue up to 2032.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
10,157 participants in 1 patient group
Loading...
Central trial contact
Xavier Jouven, MD, PhD; Jean-Philippe Empana, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal